×

Drug price rollbacks on the table: Ackman on Valeant

12:41 PM ET Mon, 2 May 2016

Discussing drug pricing, and drug access of Valeant Pharmaceutical products, with Bill Ackman, Pershing Square Capital CEO and portfolio manager.